missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human VEGF-165, AOF Recombinant Protein
Descripción
The vascular endothelial growth factor (VEGF) family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PIGF. VEGF and its receptor system have been shown to be the fundamental regulators in the cell signaling of angiogenesis. Most tumors have the absolute requirement of angiogenesis and VEGF has been described as the most potent angiogenic cytokine linked to this process. To date 5 different isoforms of VEGF have been described. These isoforms are generated as the result of alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine-kinase receptors flt-1 (VEGFR-1) and flk-1/KDR (VEGFR-2), which have been found to be expressed almost exclusively on endothelial cells.
- Purity: >95% by SDS-Page
- Endotoxin Concentration: AX41 ≤EUs/μg
- Protein Length: 166, 332 aa.
- Biological Activity: <10 ng/mL
- Molecular Weight: 19.3, 38.6 kDa
- Animal Origin Free: Yes
Especificaciones
Especificaciones
| Número de acceso | P15692 |
| Para utilizar con (aplicación) | Control, ELISA, Functional Assay, Gel Shift, Western Blot |
| Formulación | 20 mM sodium phosphate with 50 mM NaCl and no preservative |
| ID de gen (Entrez) | 7422 |
| Peso molecular | 19.3, 38.6 kDa |
| Nombre | Human VEGF-165, AOF |
| Cantidad | 100 μg |
| Fuente | E. coli |
| Requisitos de almacenamiento | -20°C |
| Estado normativo | RUO |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?